Can we allow a further intake of drugs poorly suspected as responsible in drug reaction with eosinophilia and systemic symptoms (DRESS)? A study of practice

Affiliations

¹ Department of Dermatology and Allergology, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
² Department of Dermatology, Centre Hospitalier François Quesnay, Mantes-La-Jolie, France.
³ Pharmacy department, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
⁴ Department of Dermatology and Allergology, Sorbonne Medecine University, Pharmacoepidemiology and healthcare assessment of the Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), Tenon Hospital (APHP.6), Paris, France.

Tannvir Desroche et al. Clin Exp Allergy. 2019 Jun.

. 2019 Jun;49(6):924-928.

doi: 10.1111/cea.13380. Epub 2019 Mar 26.

¹ Department of Dermatology and Allergology, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
² Department of Dermatology, Centre Hospitalier François Quesnay, Mantes-La-Jolie, France.
³ Pharmacy department, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
⁴ Department of Dermatology and Allergology, Sorbonne Medecine University, Pharmacoepidemiology and healthcare assessment of the Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), Tenon Hospital (APHP.6), Paris, France.

No abstract available

Comment in

Impact of causal uncertainty on rechallenge after dress syndrome has occurred.
Stanulović V, Venegoni M, Edwards B. Stanulović V, et al. Clin Exp Allergy. 2019 Sep;49(9):1262-1263. doi: 10.1111/cea.13451. Epub 2019 Jul 15. Clin Exp Allergy. 2019. PMID: 31219642 No abstract available.
Can we allow a further intake of drugs poorly suspected as responsible in drug reaction with eosinophilia and systemic symptoms? A study of practice.
Barbaud A, Desroche T. Barbaud A, et al. Clin Exp Allergy. 2019 Sep;49(9):1264. doi: 10.1111/cea.13462. Epub 2019 Aug 6. Clin Exp Allergy. 2019. PMID: 31313394 No abstract available.